title: Major basic protein as a marker of malignant potential in trophoblastic neoplasia.
abstract: OBJECTIVE
  We tested whether serum pregnancy-associated major basic protein levels distinguish between benign and malignant trophoblastic disease.
  
  
  METHODS
  We compared serum pregnancy-associated major basic protein levels in seven patient groups: nonpregnant and pregnant controls, partial moles, complete moles, persistent moles, placental-site trophoblastic tumors, and choriocarcinoma.
  
  
  RESULTS
  The results showed that patients with partial and complete moles had elevated serum pregnancy-associated major basic protein levels comparable to normal pregnancy. In contrast, patients with persistent mole, placental-site trophoblastic tumors and choriocarcinoma had low median serum levels comparable to those of the nonpregnant controls. Significant differences were shown between the complete and persistent mole groups (p = 0.0001) and between the complete mole group and the choriocarcinoma group (p = 0.0001); however, persistent moles were indistinguishable from choriocarcinoma (p = 0.2010).
  
  
  CONCLUSIONS
  Serum pregnancy-associated major basic protein levels thus distinguish between benign disorders, such as pregnancy and partial and complete moles, and trophoblastic tumors, such as persistent moles and choriocarcinoma. The absence of elevated serum levels of pregnancy-associated major basic protein may be useful clinically to indicate a more aggressive or frankly malignant tumor.
authors.affiliation: Department of Obstetrics, Mayo Clinic, Rochester, MN 55905, USA.
authors.forename: K V
authors.initials: KV
authors.lastname: Gurian
authors.forename: K C
authors.initials: KC
authors.lastname: Podratz
authors.forename: S A
authors.initials: SA
authors.lastname: Elg
authors.forename: L B
authors.initials: LB
authors.lastname: Twiggs
authors.forename: J R
authors.initials: JR
authors.lastname: Lurain
authors.forename: J M
authors.initials: JM
authors.lastname: Wagner
authors.forename: G J
authors.initials: GJ
authors.lastname: Gleich
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D001798:Blood Proteins; D002822:Choriocarcinoma / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D047091:Eosinophil Granule Proteins; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D015592:Immunoradiometric Assay; D011247:Pregnancy; D012260:Ribonucleases; D013997:Time Factors; D014328:Trophoblastic Neoplasms / Q000097:blood*; D018245:Trophoblastic Tumor, Placental Site / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood
chemical_list: D014408:Biomarkers, Tumor; D001798:Blood Proteins; D018997:Chorionic Gonadotropin, beta Subunit, Human; D047091:Eosinophil Granule Proteins; D012260:Ribonucleases